The relationship between QT intervals and mortality in ambulant patients with chronic heart failure
|
|
- Elmer Hodge
- 5 years ago
- Views:
Transcription
1 European Heart Journal (1999) 20, Article No. euhj , available online at on The relationship between QT intervals and mortality in ambulant patients with chronic heart failure The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART) P. Brooksby*, P. D. Batin, J. Nolan, S. J. Lindsay, R. Andrews*, M. Mullen, W. Baig, A. D. Flapan, R. J. Prescott, J. M. M. Neilson, A. J. Cowley* and K. A. A. Fox *Department of Cardiovascular Medicine, University Hospital, Nottingham; The Yorkshire Heart Centre, Leeds; Department of Cardiology and The Royal Infirmary, Doncaster; University of Edinburgh, Edinburgh, U.K. Aims Mortality in patients with heart failure remains high and is difficult to predict. QT interval parameters on a 12-lead ECG have been shown to predict arrhythmic events in patients with a variety of myocardial diseases. There is some, but not consistent, evidence that QT interval parameters may act as predictors of mortality, in particular sudden death, in patients with heart failure. In an adequately powered prospective study we have studied QT interval parameters in patients with stable chronic heart failure in order to determine whether they are predictive of all-cause mortality or mode of death. Methods and Results Five hundred and fifty-four ambulant outpatients with chronic heart failure were recruited. A 12-lead ECG, chest radiograph, echocardiogram, 24 h ambulatory electrocardiogram and serum for biochemical analysis were obtained at baseline. Patients were followed for days. QT intervals were measured in all leads blinded to patient s characteristics and outcome, were corrected for heart rate, and the maximum QT intervals, and QT dispersion (range of QT intervals) were determined. The same parameters were determined for JT intervals. The primary end-point was all-cause mortality, secondary end-points were sudden cardiac death and death due to progressive heart failure. Multivariate analysis with the Cox s proportional hazards model was used to determine which variables were independently related to outcome. Four hundred and ninety-five patients had analysable ECGs at study entry and of these 71 died during follow-up. The heart rate corrected QT dispersion and maximum QT interval were significant univariate predictors of all-cause mortality (P=0 026 and < respectively), and also of sudden death and progressive heart failure death, but were not related to outcome in the multivariate analysis. The independent predictors of all-cause mortality were cardiothoracic ratio (P=0 0003), creatinine (P=0 0009), heart rate (P=0 007), echocardiographically derived left ventricular end-diastolic dimension (P=0 007) and ventricular couplets on 24 h electrocardiographic monitoring (P=0 015). Conclusion In an adequately powered prospective study none of the QT or JT parameters were shown to be independent predictors of outcome in patients with mild to moderate congestive heart failure. These variables do not therefore add to the prognostic information which can be gained from simple radiographic, biochemical, echocardiographic and Holter data in this group of patients. (Eur Heart J 1999; 20: ) Key Words: Heart failure, congestive, electrocardiology, mortality, death, sudden, cardiac, QT intervals, QT dispersion. See page 1290 for the Editorial comment on this article Revision submitted 20 January 1999, and accepted 3 February Correspondence: Dr P. Brooksby, Department of Cardiology, Pontefract General Infirmary, Pontefract WF8 1PL, U.K X/99/ $18.00/ The European Society of Cardiology
2 1336 P. Brooksby et al. Introduction Chronic heart failure is common [1] and the mortality rate remains high despite the use of therapies proven to improve prognosis [2,3]. Although many markers of a very poor prognosis are already known [4], it remains difficult to accurately predict high and low risk groups in ambulant patients with mild to moderate symptoms and impairment of left ventricular function [5]. This remains an important task as the annual mortality rate for patients with mild to moderate chronic heart failure still exceeds 10% despite treatment with angiotensin converting enzyme inhibitors [2,5]. The two most common mechanisms of death in patients with chronic heart failure are by progressively increasing pump failure or by a sudden, unexpected deterioration [6]. In patients with mild to moderate chronic heart failure sudden death is the more common fatal event; however, current clinical techniques do not accurately predict these events [7]. Among patients fulfilling the clinical criteria for sudden cardiac death the underlying mechanism is often due to malignant ventricular arrhythmias [8,9].A common substrate for these arrhythmias is regional variation of repolarization times within the ventricular myocardium. It has been suggested that inhomogeneity of ventricular repolarization can be detected on a standard surface 12-lead ECG by measuring the QT interval and QT dispersion, which is a measure of the range of QT intervals across all 12 ECG leads [10].QT dispersion has been shown to correlate well with epicardial monophasic action potential recordings for repolarization variation [11]. QT dispersion appears to be predictive of ventricular arrhythmias in patients with ischaemic heart disease [12 15], hypertrophic cardiomyopathy [16] and congenital long QT syndromes [10]. Recently a few small studies have suggested that QT dispersion on a 12-lead ECG may be able to identify a group of chronic heart failure patients at increased risk of sudden arrhythmic death [17,18] ; however, not all studies are in agreement [19,20]. There is little data concerning the predictive power of the QT interval itself in patients with chronic heart failure, although the QT interval has been reported to be an important indicator of a high risk of sudden death in patients with ischaemic heart disease [21 24]. The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART) was designed to assess the value of non-invasive predictors of mortality in patients with chronic heart failure. We have previously reported our data relating to heart rate variability and mortality [25]. In this analysis we have examined the relationship of QT interval parameters measured on a single 12-lead ECG as independent predictors of all-cause mortality and mode of death, in comparison with known and commonly measured demographic, haemodynamic and biochemical risk factors. Methods Study design, entry criteria and organization The protocol for UK-HEART specified a prospective, multicentre design, with sample size and duration of follow-up based on a power calculation designed to ensure that the relationship between QT interval parameters and mortality would be adequately evaluated. Patient recruitment and data collection were carried out in four U.K. cardiology centres (Leeds, Nottingham, Doncaster and Edinburgh) between 1 December 1993 and 31 April Ambulant outpatients of either sex, aged between 18 and 80 years, with symptoms and objective evidence of chronic heart failure (pulmonary venous congestion, pulmonary oedema or a cardiothoracic ratio >0 55 on at least one chest radiograph, or left ventricular ejection fraction <0 45) were eligible for entry into the trial. All patients were in sinus rhythm at the time of recruitment, and were receiving diuretic therapy. In order to avoid possible confounding effects, patients were excluded if they had chronic renal impairment (creatinine >350 μmol.l 1 ), hypertrophic cardiomyopathy, myocardial infarction within the last 3 months, a history of alcohol abuse, diabetes mellitus or clinical evidence of autonomic neuropathy. QT interval measurements At enrolment a 12-lead ECG was recorded at a paper speed of 25 mm. s 1. Measurements were made using a high-resolution digitizing tablet (Summasketch III; Summagraphics) linked to an IBM compatible PC running software developed locally (Mr S. Freear, Department of Electronic Engineering, University of Leeds). All measurements were made by a single operator unaware at the time of analysis of the patient s demographics, diagnosis and other investigation results. Analysis was not possible in 59 cases, because of either unexpected atrial fibrillation, multiple ectopic beats, severely prolonged PR interval, low T wave voltages, or poor recording quality. QT intervals were measured in all 12 leads if possible, but in at least in six leads. Analysis of 10 or more leads was possible in 87% of ECGs measured. The average of three consecutive beats for each lead was taken wherever possible. The QT interval was measured from the beginning of the QRS complex to the end of the T wave. The end of the T wave was defined as the return of voltage to the isoelectric line. If a U wave was present, measurements were taken to the nadir of the curve or notch between the T and U waves. QT intervals were corrected for heart rate using Bazett s formula (QTc=QT/RR 1/2 ). The QT intervals reported are the maximum QT and QTc found on the 12-lead ECG (QT max and QTc max ). QT dispersion (QTd) and rate corrected QT dispersion (QTcd) were defined as the difference between the maximum and minimum QT and QTc intervals, respectively [10]. The JT interval, which is the time from the end of the QRS complex to
3 The UK-HEART trial 1337 the end of the T wave, was also measured. JT dispersion (JTd) was then calculated in the same way as for QTd. Patients with bundle branch block have previously been excluded from some QTd studies. These patients (n=141) were not excluded from this study, but we elected to perform a subsidiary analysis for patients without bundle branch block to determine whether the presence of an intraventricular conduction defect had a significant effect on the QT data. In patients with bundle branch block no difference between QTd (76 27 ms) and JTd (mean 75 SD 31 ms) was found (paired t-test; P=0 93), as might be expected if the abnormal QRS complex (i.e. ventricular depolarization) significantly influenced QTd. Further, no significant difference was found between the QTd measured in the bundle branch block group (76 27 ms) and patients with normal QRS morphology (71 27 ms; P=0 006), even though the maximum QT interval (QT max ) was significantly longer in the bundle branch block group ( vs ms; P<0 0001). Baseline characteristics At the recruitment visit, clinical data and demographics, NYHA class and current medical therapy were recorded. Serum was sent for biochemical analysis of renal and hepatic function. A transthoracic echocardiogram was performed and left ventricular dimensions measured at end-systole (LVESD) and end-diastole (LVEDD) according to the American Society of Echocardiography recommendations. The cardiothoracic ratio was measured from a PA chest radiograph. Twenty-four hour ambulatory electrocardiograms were recorded using a miniature tape recorder (Tracker, Reynolds Medical Ltd., U.K.). The average number of ventricular ectopic beats per hour and the presence of non-sustained ventricular arrhythmias, as defined in the V-HeFT (Vasodilator Heart Failure Trial) studies [26], was recorded for each ambulatory electrocardiogram. Mortality Patients were registered with the U.K. national death reporting scheme (Office of Population Censuses and Surveys). The primary end-point of this study was all-cause mortality. Precise sub-classification of mortality in chronic heart failure is difficult; however, previous studies have indicated that QT dispersion is only related to sudden death and not to death due to progressive heart failure. We have therefore classified deaths using criteria previously defined in chronic heart failure studies [27,28]. All deaths were classified by two physicians who were unaware of the QT interval analysis and who determined the probable mode of death after review of death certificates, autopsy findings, hospital and general practitioners records. The mode of death was classified as: (a) sudden cardiac death if it occurred within 1 h of a change in symptoms or if it occurred during sleep or while unobserved, if circumstantial evidence pointed to death from cardiovascular causes in the absence of clinical or post-mortem evidence of acute myocardial infarction or increasing heart failure; (b) progressive heart failure if death occurred after a documented period of symptomatic or haemodynamic deterioration; (c) other cardiovascular death if it did not occur suddenly and was not associated with progressively worsening heart failure; (d) non-cardiovascular death. Power calculation The number of patients studied was based upon evidence from previous work which suggested that the expected difference in QTd between survivors and those dying suddenly is around 30 ms [17]. The expected intersubject standard deviation for QTd for the two groups was 30 ms. The estimated mortality rate was 15% per annum and of these approximately 30% were likely to die suddenly. The study therefore required 500 patients to be followed for 1 year to be likely to detect a difference of 30 ms between the groups with a power of 95% and a significance level of 5%. Statistical methods Statistical analyses were undertaken by an independent statistical centre, which did not participate in patient recruitment or data collection. Descriptive group data are presented as mean standard deviation unless otherwise stated. The Cox s proportional hazards regression model [29] was used to determine which variables were related to mortality and mode of death. In order to adjust for the effects of covariates, variables that were independently associated with cardiac mortality were identified using multivariate analysis with both forward and backward stepping to protect against the omission of important predictors. Results A total of 554 patients were recruited between 1 December 1993 and 1 April Of these the 12-lead ECG was not analysable for QT parameters in 59 cases, data were therefore complete in the remaining 495 patients. Patients were followed-up for days, during which time there were 71 deaths (14 3% mortality). No patients received either an implantable defibrillator or cardiac transplant during the follow-up period. Baseline characteristics are detailed in Table 1. The majority of patients were mildly to moderately symptomatic (NYHA class: I 2 2; II 59 7%; III 37 1%; IV 1 1%). Ischaemic heart disease was the most common aetiology of chronic heart failure (76%); other causes were
4 1338 P. Brooksby et al. Table 1 Baseline characteristics of the population (n=495) Variable Mean SD Min Max Follow-up (days) Age (years) LVEDD (cm) LVESD (cm) CTR (%) NYHA class Sodium (mmol. l 1 ) Potassium (mmol. l 1 ) Creatinine (μmol.l 1 ) Albumin (mmol. l 1 ) Heart rate (beats. min 1 ) QTc max (ms) JTc max (ms) QTd (ms) QTcd (ms) JTd (ms) LVEDD=left ventricular end-diastolic diameter; LVESD=left ventricular end-systolic diameter; CTR=cardiothoracic ratio; NYHA=New York Heart Association; QTc=corrected QT intervals; max=maximum; JTc=corrected JT interval; QTd=QT dispersion; QTcd=rate corrected QT dispersion. idiopathic dilated cardiomyopathy (12%), hypertension (4%), valvular heart disease (5%) and mixed aetiology (3%). Bundle branch block was seen in 27% of the ECGs (LBBB 17%, RBBB 10%). The mean frusemide dose for the population was 73 9 mg ( 68 7) and the majority of patients were treated with an angiotensin converting enzyme inhibitor (81%). Other notable treatments for the population were digoxin (18 9%), other antiarrhythmics (chiefly amiodarone (14 6%)), and beta-blockers (8%). Univariate predictors of all-cause mortality The predictive accuracy of variables derived from clinical assessment, chest radiography, serum biochemistry, echocardiograms and ECGs were investigated initially using univariate analysis with respect to all-cause mortality. Ten variables were statistically significantly associated with all-cause mortality, and they are listed in Table 2. Of the QT parameters only QTc max and QTcd were related to mortality. However, none of the nonheart rate corrected QT parameters and none of the JT interval parameters were predictive of mortality. Multivariate predictors of all-cause mortality Multivariate analysis was undertaken in order to determine which variables were independently predictive of all-cause mortality. The five variables, which proved to be significantly related to mortality, are listed in Table 3. None of the QT parameters remained in the model as Table 2 Statistically significant univariate predictors of all cause mortality (mean SD or percentage of the population) Alive Dead P value CTR (%) < Creatinine (μmol.l 1 ) < Sodium (mmol. l 1 ) < QTc max (ms) < LVEDD (cm) HR (beats. min 1 ) Couplets 59% 81% Albumin (mmol. l 1 ) Bundle branch block 25% 39% QTcd (ms) For abbreviations see Table 1. independent predictors. The rate corrected QT parameters QTc max and QTcd lost their statistical significance when heart rate was entered into the model. This indicates that there was a significant component of heart rate, which allowed the parameters QTc max and QTcd to be univariate predictors. The significant correlations between QTc max and QTcd and other variables entered into the model are shown in Table 4. Apart from BBB and heart rate with QTc max associations that one would expect, there were no strong correlates with either of these variables. As this study included patients with bundle branch block and this might have weakened the predictive power of the QT parameters (though not the JT parameters), the analyses were repeated excluding the patients with bundle branch block. This further analysis again indicated that none of the QT parameters were independent predictors of mortality, and the same parameters as in the first analysis were predictive (i.e. cardiothoracic ratio, creatinine, heart rate, LVEDD, and the presence of couplets). Finally, the presence or absence of bundle brunch block was tested for interaction between each of the variables included in the model and no statistically significant interaction was detected. Similarly, antiarrhythmic and digitalis therapy may have influenced the results. However, when the population not taking digitalis or antiarrhythmic therapy were entered into the model there was no change in the variables that were predictive of mortality. Sudden and progressive heart failure deaths There were 24 events classified as sudden death and 30 progressive heart failure death. In patients with mild heart failure as graded by NYHA class (I and II) there were slightly more sudden deaths (3 6%) than progressive heart failure deaths (2 5%). Whereas the opposite was true for patients within NYHA class III or IV (sudden death rate 16 1%; progressive heart failure death rate 18 9%).
5 The UK-HEART trial 1339 Table 3 Statistically significant multivariate predictors of all-cause mortality Variable P value Hazard ratio (95% confidence intervals) For increase of: Cardiothoracic ratio (1 03,1 11) 1% Creatinine (1 03,1 13) 10 μmol.l 1 Heart rate (1 06,1 43) 10 beats. min 1 LVEDD (1 12,2 03) 1 cm Couplets (1 20,5 15) Present vs absent As for all-cause mortality the only QT parameters found to be significantly predictive of sudden death and progressive heart failure death on univariate analysis were QTcd (P=0 029 and respectively) and QTc max (P=0 002 and , respectively). Again, none of the QT parameters were significant independent markers of sudden death or progressive heart failure death. The variables found to be independent predictors of mode of death in the multivariate analysis are detailed in Table 5. Discussion Patients with severe chronic heart failure or multiple arrhythmias have already declared themselves to be at high risk of subsequent mortality, with survival rates at Table 4 QTc max Variable Significant correlates with (a) QTcd and (b) Pearson s correlation coefficient P value (a) QTcd Urate Heart rate LVESD LVEDD CTR BBB SVT Age Digoxin NYHA class (b) QTc max BBB Heart rate CTR LVESD LVEDD No of couplets/24 h Urate No of VEs/24 h SVTs NYHA class AST Age Albumin BBB=bundle branch block; SVT=supraventricular tachycardia; AST=asyptomatic supraventricular tachycardia. 1 year of only 40% [3]. However, among ambulant patients with clinical features of mild to moderate chronic heart failure, treated with an angiotensin converting enzyme inhibitor and diuretics, outcome varies substantially [5]. This study set out to determine whether the QT interval and QT dispersion on a single 12-lead ECG independently predict outcome in this group of patients. Previous studies addressing this issue were all limited in size and have produced conflicting results. This prospective and adequately powered study has shown that although QTc max and QTcd were strong univariate markers, they do not provide independent information regarding all-cause mortality in patients with mild to moderate chronic heart failure, and do not independently predict sudden death or death due to progressive heart failure. These parameters, therefore, do not add any further information to that which can be gained from simple radiographic, biochemical, echocardiographic and Holter data. The variables that significantly correlated with QTcd and QTc max were the main indicators of the degree of pump failure. All of the correlations were weak, however, apart from that between QTc max and the presence of bundle branch block, and QTc max and heart rate which, of course, would be expected to correlate strongly. Previous studies have also shown weak correlations between QT interval parameters and indices of left ventricular function [18,30]. It is possible that the QT interval, therefore, provides some information about the degree of left ventricular damage, possibly as a consequence of fibrotic change within the myocardium. QT intervals may also indirectly indicate the extent of cardiac pump failure by tracking the rise in catecholamine levels found in patients with chronic heart failure. Although catecholamine levels were not measured in this study, previous studies have indicated that QT dispersion does correlate well with a number of indices of sympathetic activation [31 33]. The presented results agree with some [19,20], but not all [17,18,34] published data. There are a number of potential explanations for this variability in results. The previously published studies have all had smaller sample sizes, were in the main retrospective and most did not undertake multivariate analysis. The relatively small number of deaths classified as sudden death in this study and previous studies reduces the statistical power of multivariate analyses. Indeed, in the paper by Fu et al. a combined end-point of sudden death and sustained
6 1340 P. Brooksby et al. Table 5 Statistically significant multivariate predictors of (a) sudden death and (b) progressive heart failure death Variable P value Hazard ratio (95% confidence intervals) For increase of: (a) Cardiothoracic ratio (1 03,1 16) 1% LVEDD (1 13,3 13) 1 cm Potassium (1 08,6 42) 1 mmol. l 1 (b) Creatinine (1 04,1 18) 10 μmol.l 1 Sodium (1 05,1 29) 1 mmol. l 1 Cardiothoracic ratio (1 01,1 12) 1% Couplets (1 15,9 74) Present vs absent ventricular tachycardia had to be used [18]. The definition of sudden death is particularly difficult in chronic heart failure patients and ventricular arrhythmias are responsible for only a proportion of these cases [9,35]. It follows that some of the variability in the results could be explained by differences in the classification of the mode of death, which in the majority of cases has to be made retrospectively. The mix of primary aetiologies for chronic heart failure may have had some influence, as previous work has indicated that QT dispersion was predictive of malignant arrhythmias in patients with ischaemic and not idiopathic dilated cardiomyopathy [36]. However, there does not appear to be a clear pattern as the papers by Barr et al. and Fu et al. both had a similar case mix to that of UK-HEART. The all-cause mortality rate in the studies of Barr et al., Pinsky et al. and Fu et al. were higher (17%, 27% and 30% per annum respectively) than in our study. It is possible, therefore, that QT dispersion is more predictive in patients with chronic heart failure who are at higher risk of early mortality. Unlike previous studies, we included patients with bundle branch block. However, when these patients were excluded from the analysis the results were unaffected. Finally previous studies have indicated the poor reproducibility and repeatability of QT dispersion measurements [37], and this may have a large part to play in producing the variability between the reported studies. It is important to note that the current study merely assessed the predictive value of QT parameters on an isolated, single 12-lead ECG and no serial ECGs were recorded. We cannot, therefore, determine whether dynamic temporal changes in QT parameters have prognostic significance, and this will need to be addressed by future studies. This study has demonstrated the importance of simple measures of left ventricular damage (cardiothoracic ratio and LVEDD in this study) in defining the prognosis of patients with mild to moderate symptoms of chronic heart failure. Cardiothoracic ratio was not only the most significant variable for predicting all-cause mortality, but was also the only variable, which was a significant independent variable for both sudden and progressive heart failure deaths. This result is in accordance with the V-HeFT data, which also showed the cardiothoracic ratio to be a significant independent marker of all-cause mortality, in a population of patients with a similar mortality rate [26]. We did not test the prognostic value of peak oxygen consumption or catecholamine assays in our population, since they are not routinely available to most clinicians. The data presented here for the secondary analysis of sudden and progressive heart failure deaths should be interpreted with caution, since the numbers of events are smaller and the precise definition of an individual s mode of death is exceedingly difficult even when autopsy results are available [9,35]. As previously shown in the V-HeFT study [6], sudden and progressive heart failure deaths seem mainly to be related to the severity of cardiac dysfunction. It is, however, interesting to note that extra-cellular potassium levels were significant independent risk markers for sudden death in this study. It is well known that hypokalaemia increases the risk of ventricular arrhythmias [38,39] and it is possible that this is a mechanism by which sudden deaths occur in the context of chronic heart failure. It is notable, however, that the magnitude of extra-cellular potassium fall was small and although it may predict the behaviour of a population, it is of limited value as an isolated marker of prognosis in the individual patient with chronic heart failure. Conclusion The results presented therefore indicate that QT or JT parameters, measured on a single 12-lead ECG from patients with chronic heart failure, are not significant independent markers of all-cause mortality, sudden cardiac death or progressive heart failure death. These indices do not add further information to that which can be gained from simple radiographic, biochemical, echocardiographic and Holter data. We are indebted to Debbie Blakey RGN, Liz Batin RGN and G. Borthwick for their help in data collection and to the cardiologists in Nottingham, Leeds, Edinburgh, Doncaster, Wakefield and Grimsby for referring us their patients for this study. Financial support was provided by the Chest, Heart and Stroke Association
7 The UK-HEART trial 1341 (Scotland) and the Northern and Yorkshire Research and Development Directorate. References [1] McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: [2] The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: [3] The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: [4] Rector TS, Cohn JN. Prognosis in congestive heart failure. Annu Rev Med 1994; 45: [5] Carson P, Johnson G, Fletcher R, Cohn J. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the vasodilator in heart failure trials (V-HeFT). J Am Coll Cardiol 1996; 27: [6] Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G. Mechanism of death in heart failure. The vasodilator-heart failure trials. Circulation 1993; 87 (Suppl VI): V124 V131. [7] Gradman A, Deedwania P, Cody R, Massie B, Packer M, Goldstein S. Predictors of total mortality in congestive heart failure. J Am Coll Cardiol 1989; 14: [8] De Luna AB, Coumel P, Leclerq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117: [9] Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989; 80: [10] Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: [11] Higham PD, Hilton CJ, Aitcheson JD, Furniss SS, Bourke JP, Campbell RWF. Does QT dispersion reflect dispersion of ventricular recovery? Circulation 1992; 86: I-392. [12] Higham PD, Furniss SS, Campbell RWF. Acute myocardial infarction, reperfusion and QT dispersion. J Am Coll Cardiol 1992; 19: 304A. [13] Potratz J, Wiegand U, Brandes A et al. Late potentials, heart rate variability and QT-dispersion in patients with implanted cardioverter-defibrillator (Abstr). Eur Heart J 1996; 17 (Abstr Suppl): 384. [14] Perkiomaki JS, Koistinen MJ, YliMayry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995; 26: [15] Pye M, Quinn AC, Cobe SM. QT interval dispersion: A non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J 1994; 71: [16] Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993; 72: [17] Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343 (8893): [18] Fu G-S, Meissner A, Simon R. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J 1997; 18: [19] Fei L, Goldman JH, Prasad K, Keeling PJ et al. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 1996; 17: [20] Strunk-Mueller C, Gietzen F, Kuhn H. QTc dispersion in dilated cardiomyopathy a new method for stratifying the risk of sudden cardiac death (Abstr). Eur Heart J 1996; 17 (Abstr Suppl): 276. [21] Puddu PE, Bourassa MG. Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol 1986; 19: [22] Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978; 57: [23] Peters RW, Byington RP, Barker A, Yusuf S. Prognostic value of prolonged ventricular repolarisation following myocardial infarction: the BHAT experience. J Clin Epidemiol 1990; 43: [24] Moller M. QT interval in relation to ventricular arrhythmias and sudden death in postmyocardial infarction patients. Acta Med Scand 1981; 210: [25] Nolan J, Batin PD, Andrews R et al. A prospective study of heart rate variability and mortality in chronic heart failure; Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-HEART). Circulation 1998; In press. [26] Cohn JN, Johnson GR, Shabetai R et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87 (6 S VI): V15 V16. [27] Cleland JGF Dargie HF, Ford I. Mortality in heart failure; Clinical variables of prognostic value. Br Heart J 1987; 58: [28] Greene H, Richardson D, Barker A et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic. Am J Cardiol 1989; 63: 1 6. [29] Cox DR. Regression models and life tables. J Roy Stat Soc 1972; 34: [30] Lee AFC, Hanson J, Kennedy N, Struthers AD. QT dispersion is related to an increased end diastolic volume on MUGA scan (Abstr). Eur Heart J 1996; 17 (Abstr Suppl): 277. [31] Bonnar CE, Gillespie ND, MacFayden RJ, Ogston SS, Struthers AD. QT-dispersion is significantly increased between 6am and 8am in heart failure patients a possible role in sudden death? J Am Coll Cardiol 1997; 29 (Suppl A): 510A. [32] Bonnar CE, MacFayden RJ, Robson JM, Duncan AM, Struthers AD. QT-dispersion is related to autonomic tone in patients with stable chronic heart failure (Abstr). Eur Heart J 1997; 18 (Abstr Suppl): 200. [33] Lowe MD, Ludman PF, Rowland E, Grace AA. B-adrenoceptor stimulation increases dispersion of cardiac repolarisation (Abstr). Clin Sci 1997; 93. [34] Pinsky DJ, Sciacca RR, Steinberg JS. QT dispersion as a marker of risk in patients awaiting heart transplantation. J Am Coll Cardiol 1997; 29: [35] Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation 1996; 93: [36] Cui G, Sen L, Fonarow GC et al. QT dispersion and malignant ventricular arrhythmia in patients with end-stage heart failure caused by ischemic vs. idiopathic cardiomyopathy. J Am Coll Cardiol 1996; 27 (Suppl. A): 121A. [37] Fei L, Statters DJ, Camm AJ. QT-interval dispersion on 12-lead electrocardiogram in normal subjects: Its reproducibility and relation to the T wave. Am Heart J 1994; 127: [38] Tsuij H, Veditti FJ, Evans JC, Larson MG, Levy M. The associations of levels of potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol 1994; 74: [39] Gettes L. Electrolyte abnormalities as triggers for lethal ventricular arrhythmias. In: Akhtar M, Myerburg RJ, Ruskin JN, eds. Sudden cardiac death. Philadelphia: Williams & Wilkins, 1994:
QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy
European Heart Journal (1996) 17, 258-263 QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy L. Fei, J. H. Goldman,
More informationQT Dispersion in Acute Myocardial Infarction with Special Reference to Left Ventriculographic Findings
QT Dispersion in Acute Myocardial Infarction with Special Reference to Left Ventriculographic Findings Yoshitaka DOI, M.D., Kazuyuki TAKADA, M.D., Hiroyuki MIHARA, M.D., Tomoki KAWANO, M.D., Osamu NAKAGAKI,
More informationUNDERSTANDING YOUR ECG: A REVIEW
UNDERSTANDING YOUR ECG: A REVIEW Health professionals use the electrocardiograph (ECG) rhythm strip to systematically analyse the cardiac rhythm. Before the systematic process of ECG analysis is described
More informationSriram Padmanabhan, MD, Helme Silvet, MD, Jatin Amin, MD, and Ramdas G. Pai, MD Loma Linda, Calif
Congestive Heart Failure Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: Results from a cohort of 2265 patients with an ejection fraction of
More informationArrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh
Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention
More informationStudy Day 1 Study Days 2 to 9 Sequence 1 Placebo for moxifloxacin Study Days 2 to 8: placebo for pazopanib (placebopaz) 800 mg;
The study listed may include approved non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationVentricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC
Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of
More information20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1
Symposium 39 45 1 1 2005 2008 108000 59000 55 1 3 0.045 1 1 90 95 5 10 60 30 Brugada 5 Brugada 80 15 Brugada 1 80 20 2 12 X 2 1 1 brain natriuretic peptide BNP 20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney
More information4/14/15. The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J.
The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J. Wellens MD 1 Einthoven, 1905 The ECG! Everywhere available! Easy and rapid
More informationMethods. Washington, DC and Hines, Illinois
942 JACC Vol. 32, No. 4 Prevalence and Significance of Nonsustained Ventricular Tachycardia in Patients With Premature Ventricular Contractions and Heart Failure Treated With Vasodilator Therapy STEVEN
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review
More informationPrediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring
Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Yu-Zhen ZHANG, M.D.,* Shi-Wen WANG, M.D.,* Da-Yi Hu, M.D.,**
More informationIt has been shown from meta-analysis of randomized clinical trials that patients with a pre-crt QRS duration (QRSD) >150 ms benefit
Cardiac Resynchronization Therapy may be detrimental in patients with a Very Wide QRSD > 180 ms (VWQRSD) and Right Bundle Branch Block Morphology: Analysis From the Medicare ICD Registry Varun Sundaram
More informationMy Patient Needs a Stress Test
My Patient Needs a Stress Test Amy S. Burhanna,, MD, FACC Coastal Cardiology Cape May Court House, New Jersey Absolute and relative contraindications to exercise testing Absolute Acute myocardial infarction
More informationJournal of the American College of Cardiology Vol. 35, No. 3, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 3, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00608-7 The Prognostic
More informationHeart Failure Treatments
Heart Failure Treatments Past & Present www.philippelefevre.com Background Background Chronic heart failure Drugs Mechanical Electrical Background Chronic heart failure Drugs Mechanical Electrical Sudden
More informationPolypharmacy - arrhythmic risks in patients with heart failure
Influencing sudden cardiac death by pharmacotherapy Polypharmacy - arrhythmic risks in patients with heart failure Professor Dan Atar Head, Dept. of Cardiology Oslo University Hospital Ullevål Norway 27.8.2012
More informationQUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY:
QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY: First, there are two possibilities: I) It is not known, if the patient (subject) presented
More informationC. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra
C. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra Cardiovascular Department, Ospedali Riuniti and University, Trieste, Italy PURPOSE Sex differences exist
More informationG Lin, R F Rea, S C Hammill, D L Hayes, P A Brady
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA Correspondence to: Dr Peter A Brady, MD, FRCP, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA; brady.peter@mayo.edu Accepted
More informationDiploma in Electrocardiography
The Society for Cardiological Science and Technology Diploma in Electrocardiography The Society makes this award to candidates who can demonstrate the ability to accurately record a resting 12-lead electrocardiogram
More informationMEDICINAL PRODUCTS FOR THE TREATMENT OF ARRHYTHMIAS
MEDICINAL PRODUCTS FOR THE TREATMENT OF ARRHYTHMIAS Guideline Title Medicinal Products for the Treatment of Arrhythmias Legislative basis Directive 75/318/EEC as amended Date of first adoption November
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationRita Calé, Miguel Mendes, António Ferreira, João Brito, Pedro Sousa, Pedro Carmo, Francisco Costa, Pedro Adragão, João Calqueiro, José Aniceto Silva.
Peak Circulatory Power : a new parameter of cardiopulmonary exercise testing to predict arrhythmic events in patients with implantable cardioverter defibrillator for primary prevention Rita Calé, Miguel
More informationDysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias
Dysrhythmias Dysrythmias & Anti-Dysrhythmics Rhythm bad in the heart: Whitewater rafting Electrical impulses coordinate heart Reduction in Cardiac Output PEA Asystole Components of an ECG Wave EKG Parameters
More informationMethods. progression of left ventricular systolic dysfunction in. (J Am Coll Cardiol 1998;32: ) 1998 by the American College of Cardiology
695 Atrial Fibrillation Is Associated With an Increased Risk for Mortality and Heart Failure Progression in Patients With Asymptomatic and Symptomatic Left Ventricular Systolic Dysfunction: A Retrospective
More informationCardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski
Cardiac arrhythmias Janusz Witowski Department of Pathophysiology Poznan University of Medical Sciences A 68-year old man presents to the emergency department late one evening complaining of increasing
More informationVentricular arrhythmias
Ventricular arrhythmias Assoc.Prof. Lucie Riedlbauchová, MD, PhD Department of Cardiology University HospitalMotol and2nd FacultyofMedicine, Charles University in Prague Definition and classification Ventricular
More informationECTOPIC BEATS: HOW MANY COUNT?
ECTOPIC BEATS: HOW MANY COUNT? Rupert FG Simpson, 1 Jessica Langtree, 2 *Andrew RJ Mitchell 2 1. King s College Hospital, London, UK 2. Jersey General Hospital, Jersey, UK *Correspondence to mail@jerseycardiologist.com
More informationCongestive Heart Failure or Heart Failure
Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?
More informationSynopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist
Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal
More informationQT Interval: The Proper Measurement Techniques.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 2, April 2010 http://semj.sums.ac.ir/vol11/apr2010/88044.htm QT Interval: The Proper Measurement Techniques. Basamad Z*. * Assistant Professor,
More informationDr. A. Manjula, No. 7, Doctors Quarters, JLB Road, Next to Shree Guru Residency, Mysore, Karnataka, INDIA.
Original Article In hypertensive patients measurement of left ventricular mass index by echocardiography and its correlation with current electrocardiographic criteria for the diagnosis of left ventricular
More informationComparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure
HOT TOPIC Cardiology Journal 2010, Vol. 17, No. 6, pp. 543 548 Copyright 2010 Via Medica ISSN 1897 5593 Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart
More information12-Lead ECG Interpretation. Kathy Kuznar, RN, ANP
12-Lead ECG Interpretation Kathy Kuznar, RN, ANP The 12-Lead ECG Objectives Identify the normal morphology and features of the 12- lead ECG. Perform systematic analysis of the 12-lead ECG. Recognize abnormalities
More informationClinical Policy: Holter Monitors Reference Number: CP.MP.113
Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of
More informationCardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides
Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationThe benefit of treatment with -blockers in heart failure is
Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial Philippe Lechat, MD, PhD; Jean-Sébastien Hulot, MD; Sylvie Escolano, MD, PhD; Alain Mallet,
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationClinical Cardiac Electrophysiology
Clinical Cardiac Electrophysiology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: signal_averaged_ecg 7/1992 10/2017 10/2018 10/2017 Description of Procedure or Service Signal-averaged electrocardiography
More informationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response
More informationElectrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III)
Journal of Rare Cardiovascular Diseases 2017; 3 (3): 81 85 www.jrcd.eu ORIGINAL PAPER Diseases of the heart Electrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III) Justyna
More informationNoninvasive Predictors of Sudden Cardiac Death
2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial
More informationInnovation therapy in Heart Failure
Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure
More informationICD Treatment in Patients with Severe Ventricular Tachycardia
386 September 2001 ICD Treatment in Patients with Severe Ventricular Tachycardia O.T. GRECO, A. CARDINALLI NETO, M.J. SOARES, A.C. BRANDI, C.A. SANTOS, J.M. BRANDI, D.M. BRAILE Hospital de Base, Faculdade
More informationSUDDEN CARDIAC DEATH(SCD): Definition
SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY
More informationRACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION
RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION DANIEL L. DRIES, M.D., M.P.H., DEREK V. EXNER, M.D., BERNARD J. GERSH,
More informationSignal-Averaged Electrocardiography (SAECG)
Medical Policy Manual Medicine, Policy No. 21 Signal-Averaged Electrocardiography (SAECG) Next Review: April 2018 Last Review: April 2017 Effective: May 1, 2017 IMPORTANT REMINDER Medical Policies are
More informationThe Efficient and Smart Methods for Diagnosis of SVT 대구파티마병원순환기내과정병천
The Efficient and Smart Methods for Diagnosis of SVT 대구파티마병원순환기내과정병천 Differentiation Supraventricular Origin from Ventricular Origin on ECG. QRS-Complex Width. 1. Narrow QRS-Complex Tachycardia (
More informationComparison with plasma angiotensin II and endothelin-1
European Heart Journal (1999) 2, 1799 187 Article No. euhj.1999.1746, available online at http://www.idealibrary.com on Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality
More informationSUDDEN CARDIAC DEATH(SCD): Definition
SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY
More informationREtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book
Test-Enhanced Learning Test-Enhanced Learning Test-Enhanced Learning Test-Enhanced Learning based ECG practice E-book REtrive REpeat RElearn Design by S I T T I N U N T H A N G J U I P E E R I Y A W A
More informationMEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY T-wave alternans is considered investigational as a technique
More informationStudy population The study population comprised patients with NIDCM and asymptomatic NSVT. The inclusion criteria were:
Amiodarone versus implantable cardioverter-defibrillator: randomized nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT Strickberger S A, Hummel J D, Bartlett
More informationPrognostic Significance of Atrial Fibrillation is a Function of Left Ventricular Ejection Fraction
Clin. Cardiol. 3, 349 354 (27) Prognostic Significance of Atrial Fibrillation is a Function of Left Ventricular Ejection Fraction Ramdas G. Pai, M.D. and Padmini Varadarajan, M.D. Loma Linda University
More informationImplantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk
More informationCardiac Considerations and Care in Children with Neuromuscular Disorders
Cardiac Considerations and Care in Children with Neuromuscular Disorders - importance of early and ongoing treatment, management and available able medications. Dr Bo Remenyi Department of Cardiology The
More informationICD in a young patient with syncope
ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece Case presentation A 17-year-old apparently healthy
More informationCONGESTIVE HEART FAILURE IN PATIENTS WITH SYSTEMIC HYPERTENSION: A RETROSPECTIVE ANALYSIS WITH GATED BLOODPOOL SCINTIGRAPHY
CONGESTIVE HEART FAILURE IN PATIENTS WITH SYSTEMIC HYPERTENSION: A RETROSPECTIVE ANALYSIS WITH GATED BLOODPOOL SCINTIGRAPHY Abstract L. Beÿer & A.C. Otto Congestive heart failure (CHF) is a clinical syndrome
More informationThe pill-in-the-pocket strategy for paroxysmal atrial fibrillation
The pill-in-the-pocket strategy for paroxysmal atrial fibrillation KONSTANTINOS P. LETSAS, MD, FEHRA LABORATORY OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL OF ATHENS ARRHYTHMIAS UPDATE,
More informationRate of Heart failure guideline adherence in a tertiary care center in India after accounting for the therapeutic contraindications.
Article ID: WMC004618 ISSN 2046-1690 Rate of Heart failure guideline adherence in a tertiary care center in India after accounting for the therapeutic contraindications. Peer review status: No Corresponding
More informationStudy of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri
Original Research Article Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri P. Sasikumar * Department of General Medicine, Govt.
More informationArrhythmias Focused Review. Who Needs An ICD?
Who Needs An ICD? Cesar Alberte, MD, Douglas P. Zipes, MD, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN Sudden cardiac arrest is one of the most common causes
More informationMEDICAL POLICY SUBJECT: MICROVOLT T-WAVE ALTERNANS
MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationOnline Appendix (JACC )
Beta blockers in Heart Failure Collaborative Group Online Appendix (JACC013117-0413) Heart rate, heart rhythm and prognostic effect of beta-blockers in heart failure: individual-patient data meta-analysis
More informationA Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE
A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE Adele Greyling Dora Nginza Hospital, Port Elizabeth SA Heart November 2017 What are the guidelines based on? MADIT-II Size:
More informationNCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities
More informationPause-induced Ventricular Tachycardia: Clinical Characteristics
Pause-induced Ventricular Tachycardia: Clinical Characteristics Margaret Bond A. Study Purpose and Rationale Until three decades ago, ventricular arrhythmias were thought to be rare in occurrence and their
More informationSafety of Transvenous Temporary Cardiac Pacing in Patients with Accidental Digoxin Overdose and Symptomatic Bradycardia
General Cardiology Cardiology 2004;102:152 155 DOI: 10.1159/000080483 Received: December 1, 2003 Accepted: February 12, 2004 Published online: August 27, 2004 Safety of Transvenous Temporary Cardiac Pacing
More informationSudden Cardiac Death in Sports: Causes and Current Screening Recommendations
Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and
More informationPresenter Disclosure Information
Various Morphological Types of Ventricular Premature Beats with Fragmented QRS Waves on 12 Lead Holter ECG had a Positive Relationship with Left Ventricular Fibrosis on CT in Patients with Hypertrophic
More informationManagement Strategies for Advanced Heart Failure
Management Strategies for Advanced Heart Failure Mary Norine Walsh, MD, FACC Medical Director, HF and Cardiac Transplantation St Vincent Heart Indianapolis, IN USA President American College of Cardiology
More informationLEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?
LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR? Juan Cinca Department and Chair of Cardiology Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona
More informationRhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014
Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Financial disclosures Consultant Medtronic 3 reasons to evaluate and treat arrhythmias
More informationRecommended Evaluation Data Excerpt from NVIC 04-08
Recommended Evaluation Data Excerpt from NVIC 04-08 Purpose: This document is an excerpt from the Medical and Physical Evaluations Guidelines for Merchant Mariner Credentials, contained in enclosure 3
More informationAF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
More informationSudden cardiac death: Primary and secondary prevention
Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)
More informationP. Brugada 1, R. Brugada 2 and J. Brugada 3. Introduction. U.S.A.; 3 Unitat d Arritmias, Hospital Clinic, Barcelona, Spain
European Heart Journal (2000) 21, 321 326 Article No. euhj.1999.1751, available online at http://www.idealibrary.com on Sudden death in patients and relatives with the syndrome of right bundle branch block,
More informationCharacteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls
672 Acta Cardiol 2015; 70(6): 672-677 doi: 10.2143/AC.70.6.3120179 [ Original article ] Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls
More informationSupplementary Online Content
Supplementary Online Content Wahbi K, Meune C, Porcher R, et al. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. JAMA.
More informationDifferences in the Slope of the QT-RR Relation Based on 24-Hour Holter ECG Recordings between Cardioembolic and Atherosclerotic Stroke
ORIGINAL ARTICLE Differences in the Slope of the QT-RR Relation Based on 24-Hour Holter ECG Recordings between Cardioembolic and Atherosclerotic Stroke Akira Fujiki 1 and Masao Sakabe 2 Abstract Objective
More informationThe Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia
The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology
More informationBeta blockers as cardioprotective agents: Part II Focus on prevention of sudden
Beta blockers as cardioprotective agents: Part II Focus on prevention of sudden cardiac death Sidney Goldstein, MD From the Division of Cardiovascular Medicine, Henry Ford Heart and Vascular Institute,
More informationAn Overview of the Management of Congestive Heart Failure in Malta
Original Article An Overview of the Management of Congestive Heart Failure in Malta Stuart Schembri, David Sammut, Nicola Camilleri Abstract Background: In July 2003 the National Institute of Clinical
More informationHeart Failure. GP Update Refresher 18 th January 2018
GP Update Refresher 18 th January 2018 Heart Failure Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK President of British
More informationCME Article Brugada pattern masking anterior myocardial infarction
Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University
More informationModule 1: Introduction to ECG & Normal ECG
Module 1: Introduction to ECG & Normal ECG Importance of Correct anatomical positions Measurements & Morphologies ONLY accurate if Precise anatomical positions adhered to Standardised techniques are used
More informationChapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy
Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More informationErrors in manual measurement of QT intervals
386 Br Heart_J 1994;71:386-390 MEASUREMENT Regional Medical Physics Department, Freeman Hospital, Newcastle upon Tyne A Murray N B McLaughlin Academic Cardiology Department, Freeman Hospital, Newcastle
More informationDANIEL L. DRIES, MD, MPH,* YVES D. ROSENBERG, MD, MPH,* MYRON A. WACLAWIW, PHD, MICHAEL J. DOMANSKI, MD*
1074 JACC Vol. 29, No. 5 Ejection Fraction and Risk of Thromboembolic Events in Patients With Systolic Dysfunction and Sinus Rhythm: Evidence for Gender Differences in the Studies of Left Ventricular Dysfunction
More informationThe JT Interval as a Depolarization Independent Measurement of Repolarization: Lessons from Catheter Ablation of the Wolff-Parkinson-White Syndrome
The JT Interval as a Depolarization Independent Measurement of Repolarization: Lessons from Catheter Ablation of the Wolff-Parkinson-White Syndrome MUBADDA A. SALIM, CHRISTOPHER L. CASE,' and PAUL C. CILLETTE*
More informationFrom left bundle branch block to cardiac failure
OF JOURNAL HYPERTENSION JH R RESEARCH Journal of HYPERTENSION RESEARCH www.hypertens.org/jhr Original Article J Hypertens Res (2017) 3(3):90 97 From left bundle branch block to cardiac failure Cătălina
More informationECGs and Arrhythmias: Family Medicine Board Review 2012
Overview ECGs and Arrhythmias: Family Medicine Board Review 2012 Jess Waldura, MD University of California, San Francisco walduraj@nccc.ucsf.edu Bundle branch blocks Quick review of ischemia Arrhythmias
More informationECGs and Arrhythmias: Family Medicine Board Review 2009
Rate Rhythm Intervals Hypertrophy ECGs and Arrhythmias: Family Medicine Board Review 2009 Axis Jess (Fogler) Waldura, MD University of California, San Francisco walduraj@nccc.ucsf.edu Ischemia Overview
More information